Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA

被引：2
|
作者：
Zheng, Lang [1 ,2 ]
Wang, Wenjing [1 ,2 ,3 ]
Sun, Qiu [1 ,2 ,3 ]
机构：
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[3] Sichuan Univ, West China Hosp, West China Med Publishers, Chengdu 610041, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2024年 / 9卷 / 01期
关键词：
D O I：
10.1038/s41392-024-01770-y
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：9
相关论文
共 50 条
  • [1] Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA
    Lang Zheng
    Wenjing Wang
    Qiu Sun
    [J]. Signal Transduction and Targeted Therapy, 9
  • [2] Approvals by the China NMPA in 2023
    Xiecheng Zhi
    Qiu Li
    Liming Shao
    [J]. Nature Reviews Drug Discovery, 2024, 23 : 164 - 165
  • [3] Approvals by the China NMPA in 2023
    Zhi, Xiecheng
    Li, Qiu
    Shao, Liming
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (03) : 164 - 165
  • [4] 2023 FDA approvals
    Asher Mullard
    [J]. Nature Reviews Drug Discovery, 2024, 23 (2) : 88 - 95
  • [5] FDA new drug approvals in Q2 2023
    Urquhart, Lisa
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 614 - 614
  • [6] Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023
    Martins, Alexander C.
    Oshiro, Mariana Y.
    Albericio, Fernando
    de la Torre, Beatriz G.
    [J]. BIOMEDICINES, 2024, 12 (09)
  • [7] FDA new drug approvals in Q2 2023
    Lisa Urquhart
    [J]. Nature Reviews Drug Discovery, 2023, 22 : 614 - 614
  • [8] FDA new drug approvals in Q1 2023
    Urquhart, Lisa
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (05) : 346 - 346
  • [9] FDA new drug approvals in Q1 2023
    Lisa Urquhart
    [J]. Nature Reviews Drug Discovery, 2023, 22 : 346 - 346
  • [10] FDA new drug approvals in Q3 2023
    Verdin, Paul
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (12) : 946 - 946
12345